155 related articles for article (PubMed ID: 33514018)
1. Nanostructured Lipid Carriers Engineered as Topical Delivery of Etodolac: Optimization and Cytotoxicity Studies.
Czajkowska-Kośnik A; Szymańska E; Czarnomysy R; Jacyna J; Markuszewski M; Basa A; Winnicka K
Materials (Basel); 2021 Jan; 14(3):. PubMed ID: 33514018
[TBL] [Abstract][Full Text] [Related]
2. Nanostructured Etodolac Carriers in Transdermal Gel: Optimization and Characterization.
Patil P; Shirkhedkar A
Pharm Nanotechnol; 2023 Jun; 11(3):276-293. PubMed ID: 36635925
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured Lipid Carriers (NLC)-Based Gel Formulations as Etodolac Delivery: From Gel Preparation to Permeation Study.
Czajkowska-Kośnik A; Szymańska E; Winnicka K
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615429
[TBL] [Abstract][Full Text] [Related]
4. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
Daru; 2011; 19(1):23-32. PubMed ID: 22615636
[TBL] [Abstract][Full Text] [Related]
5. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
[TBL] [Abstract][Full Text] [Related]
6. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies.
Gadhave DG; Kokare CR
Drug Dev Ind Pharm; 2019 May; 45(5):839-851. PubMed ID: 30702966
[TBL] [Abstract][Full Text] [Related]
8. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells.
Costa CP; Cunha S; Moreira JN; Silva R; Gil-Martins E; Silva V; Azevedo L; Peixoto AF; Sousa Lobo JM; Silva AC
Int J Pharm; 2021 Sep; 607():120933. PubMed ID: 34324988
[TBL] [Abstract][Full Text] [Related]
9. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition.
Rapalli VK; Kaul V; Waghule T; Gorantla S; Sharma S; Roy A; Dubey SK; Singhvi G
Eur J Pharm Sci; 2020 Sep; 152():105438. PubMed ID: 32598913
[TBL] [Abstract][Full Text] [Related]
10. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
[TBL] [Abstract][Full Text] [Related]
11. Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters.
Cunha S; Costa CP; Loureiro JA; Alves J; Peixoto AF; Forbes B; Sousa Lobo JM; Silva AC
Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32605177
[TBL] [Abstract][Full Text] [Related]
12. Nanostructured Lipid Carrier-Based Gel for Repurposing Simvastatin in Localized Treatment of Breast Cancer: Formulation Design, Development, and In Vitro and In Vivo Characterization.
Kumbhar PS; Manjappa AS; Shah RR; Nadaf SJ; Disouza JI
AAPS PharmSciTech; 2023 Apr; 24(5):106. PubMed ID: 37085596
[TBL] [Abstract][Full Text] [Related]
13. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
Zhao X; Sun Y; Li Z
Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
[TBL] [Abstract][Full Text] [Related]
14. Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy.
Ferreira M; Chaves LL; Lima SA; Reis S
Int J Pharm; 2015 Aug; 492(1-2):65-72. PubMed ID: 26169145
[TBL] [Abstract][Full Text] [Related]
15. Topical Allopurinol-Loaded Nanostructured Lipid Carriers: A Novel Approach for Wound Healing Management.
Varrica C; Carvalheiro M; Faria-Silva C; Eleutério C; Sandri G; Simões S
Bioengineering (Basel); 2021 Nov; 8(12):. PubMed ID: 34940345
[TBL] [Abstract][Full Text] [Related]
16. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
Rizwanullah M; Amin S; Ahmad J
J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
[TBL] [Abstract][Full Text] [Related]
17. Topical phenytoin nanostructured lipid carriers: design and development.
Motawea A; Borg T; Abd El-Gawad AEH
Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451
[TBL] [Abstract][Full Text] [Related]
18. A Full Factorial Design to Optimize Aminexil Nano Lipid Formulation to Improve Skin Permeation and Efficacy Against Alopecia.
Makky AMA; S El-Leithy E; Hussein DG; Khattab A
AAPS PharmSciTech; 2023 Jan; 24(1):40. PubMed ID: 36653508
[TBL] [Abstract][Full Text] [Related]
19. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
Nagaich U; Gulati N
Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
[TBL] [Abstract][Full Text] [Related]
20. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
Gadhave DG; Tagalpallewar AA; Kokare CR
AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
